Neuropace, Inc. Share Price

Neuropace, Inc. Share Price

NASDAQ: NPCE | Small Cap
$12.25
-$0.72 (-5.59%) Last updated on 31 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Neuropace, Inc. Stock Performance

Open
$12.69
Prev. Close
$12.97
Circuit Range
N/A
Day Range
$12.28 - $12.69
Year Range
$9.28 - $19.57
Volume
2,338
Average Traded
$12.41

Neuropace, Inc. Share Price Today

As of 31 October 2026, Neuropace, Inc.'s share price is $12.25. The stock opened at $12.69, compared to its previous close of $12.97. During today's trading session, Neuropace, Inc.'s share price traded between $12.28 and $12.69, with an average price of $12.48. Over the past 52 weeks, the stock has recorded a high of $19.57 and a low of $9.28. In terms of performance, Neuropace, Inc.'s share price has declined by 27.39% over the last six months and is up 23.49% on a year-on-year basis.

Neuropace, Inc. Share Price Chart

Line chart of the Neuropace, Inc. price trend over the selected period. The price fell overall, ranging from 12.25 to 12.87, ending at 12.25.
$12.28$12.69
L
Show Current Price
H

Neuropace, Inc. Stock Fundamentals & Key Indicators

Market Cap
$400.85M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.56
Revenue (TTM)
$99.99B
Return On Equity (TTM)
-160.85%
Profit Margin
-21.47%
Debt to Equity
4.97
Quarterly Earnings Growth YoY
-77.14%

Neuropace, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$27.35$26.59$22.07$22.83
Net Profit-$3.50-$2.73-$6.69-$6.20
Net Profit Margin-12.80%-10.27%-30.31%-27.16%
Income ChangeN/A22.00%-145.05%7.32%

Neuropace, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$45.52$65.42$79.91$99.99
Net Profit-$47.08-$32.96-$27.14-$21.47
Net Profit Margin-103.43%-50.38%-33.96%-21.47%
Income ChangeN/A29.99%17.66%20.89%

About Neuropace, Inc.

NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.

Neuropace, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$13.55
$12.28
-10.76%
Sep 2026
$14.52
$13.76
-2.58%
Aug 2026
$13.22
$14.13
+10.05%
Jul 2026
$16.11
$12.84
-19.28%
Jun 2026
$16.25
$15.90
-3.40%
May 2026
$16.92
$16.46
-2.43%
Apr 2026
$13.66
$16.87
+28.39%
Mar 2026
$14.28
$13.14
-9.57%
Feb 2026
$15.38
$14.53
-3.97%
Jan 2026
$15.18
$15.13
-2.13%
Dec 2025
$16.33
$15.46
-5.47%
Nov 2025
$9.48
$16.36
+64.87%

NPCE Share Price FAQs